Cargando…
Targeting of somatostatin receptors expressed in blood cells using quantum dots coated with vapreotide
Cancer may be difficult to target, however, if cancer targeted this provides the chance for a better and more effective treatment. Quantum dots (Qdots) coated vapreotide (VAP) as a somatostatin receptors (SSTRs) agonist can be efficient targeting issue since may reduce side effects and increase drug...
Autores principales: | Abdellatif, Ahmed A.H., Abou-Taleb, Heba A., Abd El Ghany, Ahmed A., Lutz, Ilka, Bouazzaoui, Abdellatif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260484/ https://www.ncbi.nlm.nih.gov/pubmed/30532637 http://dx.doi.org/10.1016/j.jsps.2018.07.004 |
Ejemplares similares
-
Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018) -
Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
por: O'Byrne, K J, et al.
Publicado: (1999) -
Formulation and evaluation of simvastatin polymeric nanoparticles loaded in hydrogel for optimum wound healing purpose
por: Farghaly Aly, Usama, et al.
Publicado: (2019) -
Somatostatin receptors as a new active targeting sites for nanoparticles
por: Abdellatif, Ahmed A.H., et al.
Publicado: (2018) -
Biomedical Applications of Quantum Dots: Overview, Challenges, and Clinical Potential
por: Abdellatif, Ahmed A H, et al.
Publicado: (2022)